Transanal endoscopic microsurgery for giant benign rectal tumours: is large size a contraindication?

Int J Colorectal Dis. 2017 Dec;32(12):1759-1761. doi: 10.1007/s00384-017-2910-9. Epub 2017 Sep 30.

Abstract

Purpose: The purpose of this study is to look at our early postoperative results, recurrence rates and need for further radical surgery in treating large (> 5 cm) rectal tumours by transanal endoscopic microsurgery (TEM).

Methods: Patients who underwent TEM for rectal tumours greater than 5 cm were included. Tumour diameter was determined based on fresh specimen measurements. We recorded the demographics, operative details, final pathology, length of hospital stay, complications and recurrence rates.

Results: Mean tumour size was 5.9 ± 1.5 cm. 68.4% of tumours (13/19) were in the middle part of the rectum. Three patients (15.8%) developed postoperative complications: two had postoperative bleeding (10.5%), one had wound dehiscence (5.3%). Three patients had involved margins (15.8%). After a median follow up of 25.2 months, there were two recurrences (10.5%). One patient developed rectal cancer 6 years after removal of rectal adenoma.

Conclusion: TEM is feasible and safe for the treatment of giant benign rectal tumours. It may be an alternative method for proctectomy in selected patients.

Keywords: Early rectal cancer; Giant rectal adenoma; Tem; Transanal endoscopic microsurgery.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Clinical Decision-Making*
  • Contraindications, Procedure*
  • Feasibility Studies
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local
  • Patient Selection*
  • Polyps / pathology
  • Polyps / surgery*
  • Rectal Neoplasms / pathology
  • Rectal Neoplasms / surgery*
  • Retrospective Studies
  • Risk Factors
  • Time Factors
  • Transanal Endoscopic Microsurgery / adverse effects*
  • Treatment Outcome
  • Tumor Burden